海洋分枝杆菌
医学
抗生素
乙胺丁醇
非结核分枝杆菌
疾病
皮肤病科
抗菌剂
重症监护医学
外科
分枝杆菌
内科学
利福平
肺结核
微生物学
病理
生物
作者
Marina Medel-Plaza,Jaime Esteban
标识
DOI:10.1080/14656566.2023.2211258
摘要
Introduction Mycobacterium marinum is a slowly growing photochromogenic nontuberculous mycobacterium that has special growth characteristics. It causes a uniquely human disease, a cutaneous syndrome named fish tank granuloma or swimming pool granuloma because of the strong epidemiological links with water. The treatment of this disease involves the use of different antimicrobials alone and in combination, depending on the severity of the disease. The antibiotics most frequently used are macrolides, tetracyclines, cotrimoxazole, quinolones, aminoglycosides, rifamycins, and ethambutol. Other approaches include the use of surgery in some cases. New treatment options, like new antibiotics, phage therapy, phototherapy, and others are currently being developed with good in vitro experimental results. In any case, the disease is usually a mild one, and the outcome is good in most of the treated patients.Areas covered We have searched the literature for treatment schemes and drugs used for treatment of M. marinum disease, as well as other therapeutic options.Expert opinion Medical treatment is the most recommended approach option, as M. marinum is usually susceptible to tetracyclines, quinolones, macrolides, cotrimoxazole, and some tuberculostatic drugs, usually used in a combined therapeutic scheme. Surgical treatment is an option that can be curative and diagnostic in small lesions.
科研通智能强力驱动
Strongly Powered by AbleSci AI